| Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post‐marketing clinical study on healthy volunteers M Del Tacca, G Pasqualetti, A Di Paolo, A Virdis, G Massimetti, G Gori, ... British journal of clinical pharmacology 68 (1), 34-42, 2009 | 97 | 2009 |
| Healthy volunteers and early phases of clinical experimentation G Pasqualetti, G Gori, C Blandizzi, M Del Tacca European journal of clinical pharmacology 66, 647-653, 2010 | 58 | 2010 |
| Clinical pharmacokinetics of antibacterials in cerebrospinal fluid A Di Paolo, G Gori, C Tascini, R Danesi, M Del Tacca Clinical pharmacokinetics 52, 511-542, 2013 | 47 | 2013 |
| Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patients C Blandizzi, M Tuccori, R Colucci, G Gori, M Fornai, L Antonioli, N Ghisu, ... Drugs & aging 25, 197-208, 2008 | 44 | 2008 |
| Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders. M Fornai, R Colucci, L Antonioli, N Ghisu, M Tuccori, G Gori, C Blandizzi, ... Methods and findings in experimental and clinical pharmacology 30 (4), 261, 2008 | 31 | 2008 |
| Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases C Tani, M Mosca, R Colucci, G Gori, A d'Ascanio, N Ghisu, M Fornai, ... Clinical and experimental rheumatology 27 (2), 321-324, 2009 | 13 | 2009 |
| CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon M Fornai, R Colucci, L Antonioli, F Baschiera, N Ghisu, M Tuccori, G Gori, ... European journal of pharmacology 557 (2-3), 212-220, 2007 | 10 | 2007 |
| Quality of Adverse Drug Reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance M Tuccori, G Giustarini, C Blandizzi, A Capogrosso-Sansone, M Rossi, ... Journal of Public Health 21, 365-372, 2013 | 8 | 2013 |
| Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers M Del Tacca, G Pasqualetti, G Gori, P Pepe, A Di Paolo, M Lastella, ... Therapeutics and Clinical Risk Management 9, 303, 2013 | 8 | 2013 |
| Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia G Gori, G Spinelli, C Spinelli, M Tuccori, C Blandizzi, M Del Tacca Nature reviews Gastroenterology & hepatology 7 (11), 642-646, 2010 | 7 | 2010 |
| Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers MD Tacca, G Pasqualetti, G Gori, P Pepe, A Di Paolo, M Lastella, ... Therapeutics and Clinical Risk Management, 303-311, 2013 | 5 | 2013 |
| GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial S Capone, FM Fusco, S Milleri, S Borrè, S Carbonara, SL Caputo, ... Cell Reports Medicine 4 (6), 2023 | 2 | 2023 |
| GRAd-COV2 vaccine provides potent and durable immunity in randomised placebo-controlled phase 2 trial (COVITAR) S Capone, FM Fusco, S Milleri, S Borrè, S Carbonara, S Lo Caputo, ... medRxiv, 2022.10. 08.22280836, 2022 | 2 | 2022 |
| Drug Experimentation in Healthy Volunteers G Gori, G Pasqualetti, C Castiglioni, C Blandizzi, M Del Tacca DRUG DEVELOPMENT–A CASE STUDY BASED INSIGHT INTO MODERN STRATEGIES, 561, 2011 | 2 | 2011 |
| Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients C Blandizzi, M Tuccori, RL Colucci, G Gori, M Fornai, L Antonioli, N Ghisu, ... DRUGS & AGING 25 (3), 197-208, 2008 | 2 | 2008 |
| GRAd-COV2 vaccine provides potent and durable immunity in a randomised placebo-controlled phase 2 trial (COVITAR)(preprint) S Capone, FM Fusco, S Milleri, S Carbonara, SL Caputo, S Leone, G Gori, ... | | 2022 |
| AN IMPROVED METHODOLOGY, BASED ON PHARMACOKINETIC, PHARMACODYNAMIC AND PHARMACOGENETIC EVALUATIONS, FOR BIOEQUIVALENCE ASSESSMENT OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS … G Gori, E Ferrannini, C Blandizzi, M Del Tacca BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 57-57, 2014 | | 2014 |
| Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations Authors' reply M Del Tacca, G Pasqualetti, G Gori, P Pepe, A Di Paolo, M Lastella, ... THERAPEUTICS AND CLINICAL RISK MANAGEMENT 9, 467-468, 2013 | | 2013 |
| Quality of Adverse Drug Reaction Reports: An Algorithm (QADRA) to Reappraise the Efficiency of Spontaneous Reporting Systems in Pharmacovigilance M Tuccori, G Giustarini, C Blandizzi, M Rossi, G Gori, F Scarpini, ... DRUG SAFETY 35, 944-944, 2012 | | 2012 |
| Analisi farmacogenetica dell’enzima TPMT in pazienti in trattamento con azatioprina G Gori, S disciplinare BIO14 | | 2011 |
